Tarrina Sends Soil and Core Samples for Testing with Results Expected April 28
Tarrina Resources (ASX:TR8) has addressed ASX’s query on recent share price movement, confirming it has dispatched soil and drill core samples for laboratory testing with results expected by late April. The company maintains strict confidentiality protocols and affirms compliance with continuous disclosure rules.
- Soil and drill core samples sent for assay testing in March and April
- Results expected by 28 April 2026 with strict confidentiality maintained
- No undisclosed information currently explains recent share price surge
- Company confirms compliance with ASX Listing Rule 3.1
- Pending assay results follow recent drilling and sampling programs
Unusual Trading Spurs ASX Price Query
Tarrina Resources (ASX:TR8) found itself under the ASX microscope after its shares jumped from 1.6 cents to an intraday high of 2.3 cents on 14 April 2026, accompanied by a significant spike in trading volume. The ASX’s price query demanded clarity on whether the company was sitting on material information yet to be disclosed that might justify this market activity.
Pending Assay Results Confirmed but Not Yet Released
This approach aligns with the company’s continuous disclosure policy and Listing Rule 3.1 obligations, which Tarrina confirmed it is fully complying with. The company denied possessing any other undisclosed information that could explain the recent share price movements, nor did it suggest any immediate plans to release assay results ahead of schedule.
Context from Recent Exploration Activity
The timing of these assays follows a period of active exploration, including the recent drilling campaign at Tarrina’s Christmas Gift Gold Project and soil sampling programs, which have been integral to refining targets. This is consistent with the company’s earlier announcements detailing its ongoing efforts to delineate mineralisation, as outlined in its recent 1,200-metre drilling program and soil sampling activities.
Investors should note that while the market has reacted to the share price movements, the company maintains that no new material information has been disclosed, and the market’s response may reflect speculation or anticipation ahead of the assay release.
Disclosure and Market Integrity Maintained
Tarrina’s detailed response to the ASX reaffirms its commitment to transparency and regulatory compliance. The company’s procedures for handling assay data and market announcements are designed to prevent premature disclosure and ensure all investors have equal access to material information. Should the assay results reveal significant new insights, Tarrina will be obliged to release them promptly, potentially triggering further market activity.
Bottom Line?
The market awaits Tarrina’s assay results due by late April, which will be a key catalyst for share price direction amid heightened speculative interest.
Questions in the middle?
- Will the pending assay results confirm the market’s apparent optimism reflected in recent trading?
- Could the assay outcomes at Christmas Gift or other projects materially shift Tarrina’s valuation?
- How will Tarrina manage disclosure if preliminary results suggest significant mineralisation?
